CIK: 0001232621 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Jan 27, 2015
Total Value ($000): $182,383 (83.1% shares, 16.9% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 4,919,625 | $49,491 | 27.1% | $12.54 | -34.9% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 2,144,387 | $39,564 | 21.7% | $10.40 | — | COM | 503459604 |
| — | SALIX PHARMACEUTICALS INC | 300,000 | $34,482 | 18.9% | $66.15 | — | COM | 795435106 |
| — | OPKO HEALTH INC | 14,000,000 | $20,573 | 11.3% | $1.47 | — | DEBT 3.0% 2/1/33 | 68375NAB9 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $16,480 | 9.0% | $62.32 | +33.4% | COM | 09061G101 |
| — | MERRIMACK PHARMACEUTICALS INC | 5,500,000 | $10,225 | 5.6% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |
| — | HORIZON PHARMA PLC | 490,000 | $6,316 | 3.5% | $12.52 | — | SHS | G4617B105 |
| — | MIRATI THERAPEUTICS INC | 238,432 | $4,416 | 2.4% | $15.15 | — | COM | 60468T105 |
| — | ONCOGENEX PHARMACEUTICALS INC | 365,000 | $836 | 0.5% | $2.29 | — | COM | 68230A106 |